Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MultiCell Technologies, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Shawn Donahue who wrote (47)	5/4/2005 11:48:40 PM
From: EACarl	Read Replies (1) \| Respond to of 237

Shawn, obviously the reverse split is not a positive, however I don't see it as the biggest problem with MUCL. As you follow the company I'm sure you are aware of the last "Q" report and the bombshell within................ "The Company has elected not to recognize revenue based on the $2.1 million minimum royalty amount for the current fiscal year, as the agreement requires such minimums to be paid by XenoTech as a condition of their exclusivity. As XenoTech could elect not to pay this amount and thereby lose exclusivity, the Company has not recognized revenues based on the minimum royalties. To date XenoTech's revenues have not approached the level required to meet the minimum royalty payments as defined in the agreement. It is the Company's belief that the collectibility of such minimum amount is not reasonably assured." The worst part of it being.............. "It is the Company's belief that the collectibility of such minimum amount is not reasonably assured." Given the facts that: 1. the Xenotech contract (and more importantly the money linked to it) was the single most important event to MUCL and now seems to be in jeopardy...... 2. Around 30 Large Pharmas were said to be in 90 day evaluations with the cells at last years shareholder meeting (almost 1 full year ago), and there is only 1 paying customer, Don't you think those are more than serious concerns? Regards, Eric.

To: Shawn Donahue who wrote (47)	5/6/2005 5:15:00 PM
From: lexi2004	Respond to of 237

Hi Shawn, I have followed EXTI.ob/MUCL.ob for at least 5+ years. They're a small company, so they have to do things that perhaps larger, more established companies might not have to do. I'm not thrilled about the RS, but what choice do they have if they want to raise the stock price in a timely fashion to attract other investors and get them closer to being off OTCBB? Personally, I think they're on the right track in a lot of ways, and are doing the best with the resources they have. Unless something major happens, I feel we will be richly rewarded. I have a large amount of shares in my IRA and just that one stock can make a big difference in the balance of it. I'm not happy that it has dropped from .51 of late to .17 or less. I have bought/traded shares at all different levels. I even bought shares for a friend at .09 when any real profits were truly questionable. Yes, I bought more at .17 and then traded those shares. I am still holding my core position and plan to do so, even if it means riding it through multiple difficulties. Let me give you an example of having faith in a company. I loaded shares of MOBL.ob when it was around .03. I traded shares, and had a core position. Out of all the stocks I trade, and I trade some expensive ones too, not just OTCBB stock, MOBL.ob was a huge winner for me. It was my best money-maker. Just recently it dipped to around .17 or so and even with the market being bad, I knew I wanted shares of it. I sold the other day for an over 50% gain on those shares, and if I had held, I would have made much more. Maybe I will be proven to be wrong, but I feel MUCL.ob will reward me for my patience over the years. Time will tell. BTW, thanks for the nice reply. Best Wishes, Lexi